Gene: DTX4
Official Full Name: deltex E3 ubiquitin ligase 4provided by HGNC
Gene Summary: Enables ubiquitin protein ligase activity. Involved in negative regulation of innate immune response; proteasome-mediated ubiquitin-dependent protein catabolic process; and protein K48-linked ubiquitination. Is active in centrosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO11413 | DTX4 Knockout cell line (HeLa) | Human | DTX4 | 1:3~1:6 | Negative | Online Inquiry |
KO11414 | DTX4 Knockout cell line (HCT 116) | Human | DTX4 | 1:2~1:4 | Negative | Online Inquiry |
KO11415 | DTX4 Knockout cell line (A549) | Human | DTX4 | 1:3~1:4 | Negative | Online Inquiry |
DTX4 Gene Knockout Cell Lines are genetically engineered cellular models specifically designed to lack the functionality of the DTX4 gene. DTX4, a crucial component of the E3 ubiquitin ligase complex, plays a significant role in regulating protein degradation and maintaining cellular homeostasis. By utilizing CRISPR-Cas9 technology, these knockout cell lines enable researchers to study the effects of DTX4 deletion on various biological pathways, enabling an understanding of its role in processes such as cell proliferation, apoptosis, and signal transduction.
The primary mechanism of action involves inhibiting the E3 ligase activity associated with DTX4, leading to alterations in the levels of target proteins involved in critical cellular functions. Without the DTX4 gene, cells exhibit unique phenotypic characteristics that can be investigated for insights into disease mechanisms, particularly in cancer biology, where protein stability and degradation pathways are frequently dysregulated. These cell lines are invaluable for experimental setups aiming to elucidate the cellular consequences of DTX4 loss, making them fundamental tools in both pharmaceutical research and broader biological studies.
The scientific importance of DTX4 Gene Knockout Cell Lines lies in their application for developing therapeutic strategies targeting protein degradation pathways. Compared to traditional overexpression or wild-type systems, knockout models provide a clearer understanding of loss-of-function mutations, thus representing a more accurate simulation of many human diseases.
Researchers and clinicians can leverage these cell lines for drug discovery, functional genomics, and biochemical assays, allowing for the exploration of novel avenues in targeted therapies. The specificity and reliability of our DTX4 knockout models distinguish them from alternatives, as they are rigorously validated for consistent performance and reproducibility across experimental conditions.
In conclusion, our company excels in producing high-quality genetic models tailored for cutting-edge research. We are committed to empowering the scientific community with robust tools that facilitate groundbreaking discoveries in molecular and cellular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.